Receptor-targeted nanocomplexes optimized for gene transfer to primary vascular cells and explant cultures of rabbit aorta

Molecular Therapy

Volumn 16, Issue 3, 2008, Pages 508-515

  Irvine, Scott A ^a   Meng, Qing Hai ^a   Afzal, Faiza ^a   Ho, Jimmy ^b   Wong, John B ^b   Hailes, Helen C ^b   Tabor, Alethea B ^b   McEwan, Jean R ^b   Hart, Stephen L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GLUCOSE; LIPID; LIPOSOME; PLASMID DNA; SODIUM CHLORIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EXPLANT; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; INCUBATION TIME; LIPID ANALYSIS; LIPOSOMAL GENE DELIVERY SYSTEM; MALE; NANOTECHNOLOGY; NONHUMAN; PROTEIN MOTIF; RABBIT; ROOM TEMPERATURE; SMOOTH MUSCLE; TRANSGENE;

ORYCTOLAGUS CUNICULUS;

EID: 39849087389     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300381     Document Type: Article

References (21)

1. AH Baker AP Yim S Wan Opportunities for gene therapy in preventing vein graft failure after coronary artery bypass surgery Diabetes Obes Metab 8 2006 119 124
2. SL Hart CV Arancibia-Carcamo MA Wolfert C Mailhos NJ O'Reilly RR Ali Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector Hum Gene Ther 9 1998 575 585
3. R Parkes QH Meng KE Siapati JR McEwan SL Hart High efficiency transfection of porcine vascular cells, in vitro with a synthetic vector system J Gene Med 4 2002 292 299
4. QH Meng W Jamal SL Hart JR McEwan Application to vascular adventitia of a nonviral vector for TIMP-1 gene therapy to prevent intimal hyperplasia Hum Gene Ther 17 2006 717 727
5. M Writer CA Hurley S Sarkar DM Copeman JB Wong M Odlyha Analysis and optimisation of the cationic lipid component of a lipid/peptide vector formulation for enhanced transfection in vitro and in vivo J Liposome Res 16 2006 373 389
6. MJ Writer B Marshall MA Pilkington-Miksa SE Barker M Jacobsen A Kritz Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage display J Drug Target 12 2004 185 193
7. SL Hart L Collins K Gustafsson JW Fabre Integrin-mediated transfection with peptides containing arginine-glycine-aspartic acid domains Gene Ther 4 1997 1225 1230
8. RP Harbottle RG Cooper SL Hart A Ladhoff T McKay A Knight An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery Hum Gene Ther 9 1998 1037 1047
9. PL Felgner TR Gadek M Holm R Roman HW Chan M Wenz Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure Proc Natl Acad Sci USA 84 1987 7413 7417
10. RG Jenkins SE Herrick QH Meng C Kinnon GJ Laurent RJ McAnulty An integrin-targeted non-viral vector for pulmonary gene therapy Gene Ther 7 2000 393 400
11. MB Izzat RR West AJ Bryan GD Angelini Coronary artery bypass surgery: current practice in the United Kingdom Br Heart J 71 1994 382 385
12. KA Eagle RA Guyton R Davidoff GA Ewy J Fonger T Gardner ACC/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). American College of Cardiology/American Heart Association J Am Coll Cardiol 34 1999 1262 1347
13. KA Eagle Update in cardiology Ann Intern Med 133 2000 439 446
14. GM FitzGibbon HP Kafka AJ Leach WJ Keon GD Hooper JR Burton Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years J Am Coll Cardiol 28 1996 616 626
15. MG Bourassa Long-term clinical results after coronary artery bypass surgery Cardiovasc Clin 21 1991 101 121
16. JH Ip V Fuster L Badimon J Badimon MB Taubman JH Chesebro Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation J Am Coll Cardiol 15 1990 1667 1687
17. MJ Mann Gene therapy for vein grafts Curr Cardiol Rep 2 2000 29 33
18. CA Hurley JB Wong HC Hailes AB Tabor Asymmetric synthesis of dialkyloxy-3-alkylammonium cationic lipids J Org Chem 69 2004 980 983
19. TA Pearson JM Dillman RH Heptinstall The clonal characteristics of human aortic intima. Comparison with fatty streaks and normal media Am J Pathol 113 1983 33 40
20. Z Jiang L Wu BL Miller D Goldman CM Fernandez ZS Abouhamze A novel vein graft model: adaptation to differential flow environments Am J Physiol Heart Circ Physiol 286 2004 H240 H245
21. GJ Wang XX Sui HF Simosa MK Jain DC Altieri MS Conte Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein Arterioscler Thromb Vasc Biol 25 2005 2081 2087